Natalie Eiland is an experienced professional in clinical research and risk evaluation and mitigation strategies (REMS), currently serving as the Director of Clinical Research at UBC since January 2024. Prior to this role, Eiland worked as a REMS Program Manager on a contract basis at Indivior from August 2021 to January 2024 and held the position of Associate Program Manager for REMS at Syneos Health from June 2018 to August 2021. Eiland's career began at Walgreens, where responsibilities included Business Analyst for Patient Safety / Pharmacovigilance and REMS Implementation as well as Senior Pharmacy Technician and Patient Care Advocate from September 2005 to June 2018. Eiland holds a degree from Loyola University Chicago, earned between 2004 and 2008.
This person is not in any teams
This person is not in any offices